MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery
The lack of a unifying metric characterizing combinatorial drug interactions has impeded the development of combinatorial therapies. Here, the authors present MuSyC, a consensus synergy metric that overcomes several caveats associated with other, popular metrics.
Main Authors: | David J. Wooten, Christian T. Meyer, Alexander L. R. Lubbock, Vito Quaranta, Carlos F. Lopez |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-24789-z |
Similar Items
-
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses
by: David Taylor, et al.
Published: (2022-08-01) -
Combinatorial drug discovery in nanoliter droplets
by: Kulesa, Anthony Benjamin, et al.
Published: (2019) -
Discovery of Natural Products With Antifungal Potential Through Combinatorial Synergy
by: Catheryn R. Augostine, et al.
Published: (2022-04-01) -
A chemogenomic HTS for combinatorial drug discovery in glioblastoma
by: Johanssen, T, et al.
Published: (2022) -
The impact of combinatorial chemistry on the pharmaceutical drug discovery process
by: Franke, Roland Rolf
Published: (2005)